Remicade Biosimilar Market to Hit USD 4.10 Billion by 2035

bir ses eklendi Networking

2025-10-31 14:17:13 -

The global Remicade Biosimilar Market, valued at USD 2.32 billion in 2025, is poised for strong growth, expected to reach USD 4.10 billion by 2035, reflecting a CAGR of 5.4%. This expansion is fueled by growing adoption in emerging economies, rapid regulatory approvals, and the drive to provide cost-effective alternatives to branded biologics. Remicade, also known as...

0 Yorumlar 0 hisse senetleri 797 Views